News

Blog y noticias

Miniatura-de-YouTube-Plan-de-Negocio-Sencillo-Moderno-Azul-1-1200x675.png
10/Apr/2024

On Wednesday 3rd April, Dr+Vet was honoured to welcome leading veterinary ophthalmologist Maria Simó for our first webinar on Keratoconjunctivitis Seca (KCS) in dogs. During this virtual event, María Simó shared her knowledge and experience in the diagnosis and treatment of this common but often underestimated eye disease. Today, we can finally announce that the full video, with subtitles in English (and other languages automatically), is available for viewing on our blog and our YouTube channel! Attached to this article, you will find the direct link to the video so you can access it and deepen the knowledge shared by María Simó.

About Maria Simó:

Maria Simó is a renowned veterinary ophthalmologist with a solid background and extensive experience in the field of veterinary ophthalmology. Graduated in Veterinary Medicine from the Autonomous University of Barcelona, María has completed several postgraduate courses and works as an ophthalmologist at the prestigious Instituto Veterinario Oftalmológico (IVO) in Barcelona.

Contenido del Webinar:

Maria Simó talked us through the basics of Keratoconjunctivitis Seca, from diagnostic methods to the most effective treatment options, exploring in detail how to approach this disease in a comprehensive way.

One of the main conclusions of the webinar was the importance of not relying solely on the Schirmer test to diagnose KCS. María Simó emphasised the need for a complete and detailed assessment, as well as the use of additional diagnostic tools for a correct diagnosis, as without all the information, ineffective treatments may be prescribed. She also talked about the importance of referring cases that do not resolve correctly in order to fully evaluate them.

 

We thank all participants for their support.

The webinar on Keratoconjunctivitis Seca with Maria Simó was a great success, and we would like to thank everyone who joined us for this educational event. We hope that this resource will be a valuable source of information for all veterinarians interested in veterinary ophthalmology. Feel free to check out the full video and share it with your colleagues.

Stay tuned to our social media and website for more information on future of Dr+Vet events and educational resources!


Spain-1200x675.png
10/Apr/2024

Dr+Vet presents its new Guide to the Diagnosis and Management of Keratoconjunctivitis Seca in Companion Pets

We are pleased to announce the launch of our latest initiative: the Guide to the Diagnosis and Management of Keratoconjunctivitis Seca (KCS) in Companion Animals. This guide has been designed to provide veterinarians with a tool to address this common ocular pathology in pets.

KCS, also known as dry eye, is a disease that affects the ocular health of animals, causing discomfort and, in severe cases, permanent damage to the cornea and conjunctiva. To help veterinary professionals diagnose and treat this condition effectively, our guide covers a wide range of topics, from the pathophysiology of the disease to treatment options and recommendations for clinical management.

Some of the guide’s topics include:

  • A detailed description of the disease and its impact on the ocular health of animals.
  • Explanation of the different types of KCS and their clinical features.
  • Diagnostic methods.
  • Treatment options, from artificial tears to more advanced therapies.

At Dr+Vet, we want to assist in everyday clinical practice by providing valuable resources to help veterinarians provide the best possible care for their furry patients.

The Keratoconjunctivitis Sicca Diagnosis and Management Guide is now available for free download on our website – don’t miss this opportunity to improve your knowledge and skills in managing your patients’ ocular health!

Click here to download: Dr+Vet. Guide for KCS for veterinarians


Spain-1200x675.png
25/Mar/2024

Keratoconjunctivitis Sicca (KCS), also known as “dry eye,” is a common ophthalmic condition in dogs and cats that affects the ocular surface, specifically the cornea and conjunctiva.

This disease results from the deficiency of some of the phases of the tear film, which leads to tear hyperosmolarity and, consequently, a series of ocular complications that can compromise the visual health of the animal.

The structure of the tear

To better understand KCS, it is important to know the three layers that make up the tear film and their functions:

  • Mucinous layer: This layer, the innermost, modifies the surface tension of the tear so that it adheres and distributes properly over the surface of the eye. Mucin is produced and secreted mainly in conjunctival goblet cells.
  • Aqueous layer: The intermediate layer, and the most abundant, hydrates the ocular surface and transports nutrients and oxygen essential for the metabolism of the cornea. It also acts as a flushing mechanism to remove debris and foreign bodies. This watery portion is produced and secreted in the main and accessory lacrimal glands.
  • Lipid layer: The outermost layer protects the aqueous layer from evaporation, allowing the tear to remain in the eye longer. In addition, it increases the surface tension of the tear, preventing overflow over the edge of the eyelid and lubricating the eyelids. This layer is produced and secreted mainly in the meibomian glands.

KCS classification

The KCS can be classified into two main types:

  • Qualitative KCS: It is produced by a pathological decrease in the lipid or mucoid components of the tear film, which makes it difficult for it to remain on the cornea, either due to excess evaporation or difficulty adhering. It is usually due to damage or inflammation in the meibomian glands or goblet cells of the conjunctiva.
  • Quantitative KCS: It is produced by a pathological decrease in the aqueous component of the tear film. It can have various causes, the most common being localized and chronic immune-mediated inflammation of the lacrimal gland. This is the most common form of KCS, and in most cases it progresses to a mixed form (quantitative and qualitative) over time.

What symptoms does it cause?

Symptoms of KCS may include mucosal exudate, conjunctival hyperemia, corneal opacity, neovascularization, corneal edema, and ulceration, among others. The diagnosis of KCS requires a thorough evaluation of the patient’s medical history and specific ophthalmological tests, such as the Schirmer Test, Fluorescein Test, and the Lysamine Green Test.

What treatment is used?

Treatment of KCS may include artificial tears, topical immunosuppressants, and surgical treatments, depending on the severity and underlying cause of the disease. Additionally, supplementation with specific nutraceuticals such as LACRIMALIS+ can help manage this disease, offering natural help to maintain pets’ eye health.

 

If your pet presents symptoms compatible with this disease, go to your trusted veterinarian for correct diagnosis and treatment.


blog-iberzoo-1200x675.png
18/Mar/2024

Iberzoo+Propet 2024, the international event for pet professionals, organized by IFEMA Madrid and promoted by the Madrid Association of Companion Animal Veterinarians (AMVAC) and the Spanish Association of Industry and Commerce of the Companion Animal Sector (Aedpac), closed its 9th edition last week. This event, a point of reference for pet professionals, brought together more than 220 nutrition, medicine and veterinary technology companies on March 13, 14 and 15, who exhibited their latest innovations and products, and thousands of veterinarians interested in the presentations and news of the sector.

The fair offered a full program of activities with various congresses and spaces, such as the Veterinary Classroom, the Aquariophilia activities, the Canine Styling Stage, the VI AEDPAC Forum, the VetMadrid Congress, the Artero Conference and the Sector Afternoon, where knowledge was shared and innovations and services designed for professionals in the sector were presented. A preview of the Sector Data Report of the Madrid Association of Companion Animal Veterinarians (AMVAC) was also presented.

Our stand at Iberzoo AMVAC Propet became a meeting point for veterinary professionals and other professionals in the sector, where we shared technical and relevant information about our products. The presentation of RetinaeXL was very well received by visitors, who showed great interest in this new nutraceutical presentation for retinal problems in large dogs.

In summary, Dr+Vet’s participation in Iberzoo AMVAC Propet 2024 was a rewarding and enriching experience. We are excited to continue advancing canine vision care with the launch of RetinaeXL and to continue collaborating with the veterinary community to improve the quality of life of our beloved pets.

We would like to take this opportunity to remind you that Maria Simó from the Ophthalmological Institute of Barcelona (IVO) will be the speaker of our first online webinar: April 3rd at 13:00h (Spain). You can register here.

Thanks to everyone who made this event possible and we hope to see you again in future editions of Iberzoo AMVAC Propet!

Photo: Animal’s Health (www.animalshealth.es)


ig-e1707836972627.png
04/Mar/2024

This event brings together thousands of professionals from the sector each year.

For the second consecutive year, Dr+Vet sponsors the Iberzoo-Propet AMVAC 2024 congress, the largest event on products and services related to pets, which will take place in Madrid from March 13 to 15.

During these days we will have the opportunity to connect with professionals from across the veterinary sector and share our latest innovations in veterinary nutraceuticals.

During this congress we will present a novelty in our ophthalmological range: RetinaeXL. The Retinae product has been part of the Dr+Vet catalog since its inception and now receives a new presentation adapted to larger breeds that suffer from hereditary idiopathic retinal degeneration.

Retinae XL: retina protection for XL dogs

The novelty of this congress is RetinaeXL. This product maintains the same formulation as Retinae but adapts its quantities to larger breeds, its recommended mode of use being 1 tablet per day for every 20kg (unlike Retinae which corresponds to 1 tablet per day for every 10kg).

Both Retinae and RetinaeXL provide nutrients to the retina, especially interesting in those breeds predisposed to retinopathies. Its main ingredients are Tagetes erecta (source of lutein and zeaxanthin) and omega 3 fatty acids that provide anti-inflammatory and antiangiogenic properties. These products also provide pets with Vitamins (C, E, B [B6, B9, B12]), Lactoferrin, Zinc and Copper.

Other product lines

In addition to our ophthalmological line, we will also be providing detailed information about our digestive and metabolic ranges, with the products Glyco, Flavum, Digestum and Colitum.

Iberzoo-Propet  serves as a platform to interact with professional colleagues and showcase our commitment to innovative veterinary care. Our team will be available to provide detailed information and answer any questions you may have about our products.

Stay tuned for updates and follow us on social media for more details as the event approaches. See you there!


XIII-COV-0865-1200x800.jpg
27/Feb/2024

On February 23rd and 24th, the XII Veterinary Ophthalmology Congress was held in Madrid, organized by SEOVET (Spanish Society of Veterinary Ophthalmology).

This year, for the third consecutive time, Dr+Vet is once again sponsoring the largest Spanish congress of veterinary ophthalmology, the SEOVET. More than 140 specialists in this field gathered to share impressions and learn from great specialists.

This year the pre-congress started on Friday with the presentation of Laura Muñoz (Founder and Medical Director of OCULARVET). This was followed by the first lecture on photography in ophthalmology given by Javier Esteban of Anicura Ocaña and then the second lecture on photography given by Raquel Udiz. Both talks provided the attending veterinarians with interesting tips to improve their imaging technique and clinical data collection.

In the afternoon the congress started with a lot of enthusiasm from all participants and attendees. During the SEOVET we could enjoy presentations given by Eva Abarca (HV Canis de Mallorca), Manolo Villagrasa (COV, HV Puchol de Madrid), Màrian Matas (Memvet de Palma), Paco Simó (IVO de Barcelona), Ángel Ortillés (Anicura Valencia Sur de Valencia) and Fernando Sanz (Visionvet de Sevilla).

The SEOVET management knew how to organize a truly dynamic, educational and entertaining conference where all veterinarians could learn the latest developments in their field and at the same time fully enjoy the company and gastronomy.

Dr+Vet had the opportunity to present directly to a specialized audience the improved version of our products GLAUCO+ and OCCULUS+.

Glauco+

One of our presentations was Glauco+, a nutritional supplement designed to address the progression of glaucoma in pets. The improved formula, which includes neuroprotective and vasodilator components in addition to citicoline, has attracted a great deal of interest from ophthalmology veterinarians who had long been asking for this improvement over the Glauco formula.

Occulus+

We also share the improvements in Occulus+. With the addition of key nutritional elements and an improved formulation with alpha lipoic acid, Occulus+ reinforces its antioxidant effect on the crystalline lens.

This year at Dr+Vet we have no plans to put on the brakes, so we are already looking forward to the next big event: Iberzoo+Propet. See you again at IFEMA Madrid from March 13-15!


prova-dr-vet-1.png
16/Jan/2024

When our pets get older, just like us, they start to require some special care and also a more exhaustive veterinary follow-up than during the rest of their lives.

From approximately 8 years of age, we recommend an annual visit where the veterinarian can check the weight, general physical condition, perform analytical or other tests if necessary. In these controls can be diagnosed diseases that do not yet have clinical signs and in which early treatment can slow the progression or development of such disease.

In this article we are going to focus on the most common vision defect in geriatric pets: cataracts. One of the most frequent ocular affections we see in the veterinary practice are cataracts. The origin of these cataracts is usually associated with age and degeneration of the crystalline lens due to the increase of its layers and the oxidative damage it suffers during its life. Other causes of cataracts can be diabetes mellitus, blows or trauma, congenital/hereditary or retinal atrophy.

How does a cataract form?
The crystalline lens is a lens formed by several layers located inside the eye, its function is to concentrate light so that it is properly projected on the retina. With the passage of time and the natural aging process, the lens tends to accumulate additional layers. This gradual process of layer accumulation can cause the lens to become denser and less transparent.

How do we detect that our pet has cataracts?
At home we can suspect the presence of cataracts and it will be the veterinarian who will confirm the diagnosis and will be able to tell us what treatment we can offer to our pet. If detected and treated in time, cataracts should not be a problem. At home we will be able to see a certain whitish or bluish opacity (at the beginning) in the crystalline lens. If the cataract is more advanced, we will clearly see the opacity or that the animal is hitting obstacles it may encounter due to the difficulty of vision.

In early stages (A,B), when it is not yet mature, there are still non-surgical treatment options such as dietary supplementation with vitamins and antioxidants to slow the onset of cataracts. Specialized nutritional supplements such as Occulus+ from Dr+Vet could be used to provide vitamins A, C, E and antioxidant minerals to slow the progression of the disease.

Once the cataract has evolved (C), a specialist veterinarian will indicate the best surgical solution, after an exhaustive review of the pet’s health and vision. Cataracts are an operable disease with a high success rate (around 90%). Post-surgical recovery usually takes a few days with anti-inflammatory eye drops and antibiotics until medical discharge.

Phases of cataract

Figure 1. Phases of cataract in dogs: A. Initial phase B. Immature cataract Immature cataract C. Mature cataract (point of surgery).
As the lens becomes less transparent and light can no longer pass through it clearly. In simple terms, the additional layers in the lens alter its original structure causing irreversible damage that affects its ability to focus light properly on the retina.

The Dr+Vet formula: Occulus+
As mentioned above, Dr+Vet offers the nutritional supplement Occulus+ recently reformulated to increase its antioxidant potential with alpha lipoic acid. This product contains abundant vitamins, minerals and antioxidant components that promote overall eye health and help slow disease progression.


Panell-mailing-i-per-PRePOST-WEBINAR-2.png
03/Jan/2024

This initiative will offer a series of lectures aimed at veterinarians in Spain and throughout Europe, with the objective of promoting continuous learning and knowledge sharing in the field of veterinary medicine.

Throughout 2024, Dr+Vet will organize a total of four keynote lectures, each addressing relevant and current topics in various areas of veterinary medicine. From internal medicine to ophthalmology, our webinar platform will offer a wide variety of topics to meet the interests and needs of all veterinary professionals.

These lectures will be delivered by leading experts in each field, who will share their knowledge, experiences and best practices with the audience. In addition, the webinars will offer the unique opportunity to interact with the speakers, asking questions and participating in real-time discussions.

The Dr+Vet webinar platform will be open to veterinarians from all over Spain and Europe, providing easy and convenient access to high quality veterinary education. Whether you’re looking to expand your knowledge, keep up with the latest developments in the field or simply connect with colleagues from across the continent, our webinar platform has something for you!

Stay tuned for more information on webinar dates and topics, as well as details on how to register and participate. We are excited to embark on this new adventure and look forward to having you on our webinars in 2024.

See you online!


Copia-de-en-nuestra-LINEA-OFTALMOLOGICA-2.png
14/Dec/2023

Keratoconjunctivitis sicca (KCS) is a condition of the ocular surface (cornea and conjunctiva) secondary to a deficiency of one of the phases of the tear film and has a prevalence in dogs of 0.4%, according to the IVO.

Qualitative QCS is characterized by a pathological decrease of lipid or mucoid components in the tear film. This leads to tear hyperosmolarity due to increased evaporation. It is more common in brachiocephalic breeds and in cases of lagophthalmos.

In this study, conducted in collaboration with the Instituto Veterinario Oftalmologico (IVO), a comprehensive evaluation of different therapeutic approaches for qualitative QCS was performed.

Ten dogs were selected, including five brachiocephalic breeds, with a two-month follow-up. The selected patients had blepharospasm, epiphora, increased serous secretions compared to normal, or a combination of these symptoms at the first visit and, in order to be included in the present study, had to have Schirmer’s test (STT-1) values above 10 mm/min.

Cases with corneal ulcer and those under treatment that could interfere with the diagnostic tests were excluded. A series of diagnostic tests were performed, such as Schirmer’s test (STT-1), fluorescein test, break-up time (TBUT), lissamine green test, impression cytology (CIC) and OSA-VET®.

The selected treatment included the use of topical moisturizers and lubricants as tear replacements. In addition, Dr+Vet’s Lacrimalis food supplement, rich in omega-3 fatty acids, lactoferrin, vitamins C and E, Zinc and Copper, was implemented.

The results indicated significant improvements in print cytology, interferometry and tear film breakup time. There was a slight reduction in tear production, possibly attributed to decreased compensatory reflex due to hyperosmolarity.

Conclusions

This clinical case comparison underscores the importance of a multidisciplinary approach in the management of qualitative QCS. The combination of topical moisturizers and lubricants with the supplement Lacrimalis offers a promising perspective in the management of this condition.

The clinical case comparison performed by the IVO provides a valuable contribution to the approach to qualitative QCS in dogs. We thank Drs. Maria Simó and Francisco Simó for their collaboration in this first approach to the use of nutraceuticals in ocular diseases in dogs.

You can consult the comparative of clinical cases here (in spanish): COMPARATIVA DE 10 CASOS CLÍNICOS EN PERROS CON KCS CUALITATIVA


Disseny-sense-titol.png
16/Nov/2023

Last week, the Dr+Vet team participated in the AVEPA SEVC congress, where we exchanged opinions and learned from high-level clinical veterinarians and at the same time we were able to share with them the novelties in our catalog:

Glauco+

One of our presentations was Glauco+, a nutritional supplement designed to address the progression of glaucoma in pets. The improved formula, which includes natural components and, most importantly, citicoline, has aroused great interest among ophthalmology veterinarians who had long been asking for this improvement over the Glauco formula.

Occulus+

In our participation in AVEPA SEVC, we also shared the improvements in Occulus+. With the addition of key nutritional elements and an improved formulation, Occulus+ reinforces its antioxidant effect in crystalline lens.

The response we received from the veterinarians who visited our booth was certainly inspiring. It fills us with gratitude to see how our products are received with enthusiasm and appreciation by professionals committed to animal welfare.

We thank all the veterinarians who came by, shared their perspectives and were part of this enriching experience.

See you at AVEPA-SEVC Madrid 2024!


Copyright by Boothmen Pharma 2023. All rights reserved.